Grant Private Wealth Management Inc Buys New Position in UnitedHealth Group Incorporated (NYSE:UNH)

Grant Private Wealth Management Inc purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH) in the fourth quarter, according to its most recent Form 13F filing with the SEC. The institutional investor purchased 1,331 shares of the healthcare conglomerate’s stock, valued at approximately $673,000.

Several other hedge funds also recently made changes to their positions in UNH. Arete Wealth Advisors LLC lifted its stake in shares of UnitedHealth Group by 33.6% in the 4th quarter. Arete Wealth Advisors LLC now owns 6,682 shares of the healthcare conglomerate’s stock valued at $3,377,000 after purchasing an additional 1,681 shares during the last quarter. Motley Fool Asset Management LLC lifted its position in shares of UnitedHealth Group by 2.3% in the fourth quarter. Motley Fool Asset Management LLC now owns 42,546 shares of the healthcare conglomerate’s stock worth $21,522,000 after buying an additional 940 shares during the last quarter. World Investment Advisors increased its holdings in shares of UnitedHealth Group by 7.8% during the 4th quarter. World Investment Advisors now owns 44,800 shares of the healthcare conglomerate’s stock valued at $22,662,000 after acquiring an additional 3,225 shares during the last quarter. Disciplined Investors L.L.C. acquired a new stake in UnitedHealth Group in the 4th quarter worth approximately $684,000. Finally, SevenBridge Financial Group LLC grew its holdings in UnitedHealth Group by 15.3% during the fourth quarter. SevenBridge Financial Group LLC now owns 8,222 shares of the healthcare conglomerate’s stock valued at $4,390,000 after purchasing an additional 1,092 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

Several research analysts recently commented on the stock. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. Piper Sandler decreased their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a research note on Thursday, January 2nd. Cantor Fitzgerald reiterated an “overweight” rating and set a $700.00 price target on shares of UnitedHealth Group in a report on Friday, January 17th. Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a research report on Tuesday, January 28th. Finally, HSBC upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price target on the stock in a research report on Friday, January 10th. Twenty analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the company. According to data from MarketBeat, the company currently has a consensus rating of “Buy” and a consensus target price of $629.32.

UnitedHealth Group Trading Up 0.1 %

Shares of UNH stock opened at $523.61 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74. The company has a market capitalization of $478.95 billion, a P/E ratio of 33.78, a P/E/G ratio of 1.37 and a beta of 0.62. UnitedHealth Group Incorporated has a 12-month low of $436.38 and a 12-month high of $630.73. The firm has a 50-day moving average price of $509.15 and a 200 day moving average price of $542.83.

UnitedHealth Group (NYSE:UNH) last released its quarterly earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share for the quarter, beating analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm had revenue of $100.81 billion during the quarter, compared to analysts’ expectations of $101.60 billion. During the same period last year, the firm posted $5.83 EPS. The business’s revenue was up 6.8% on a year-over-year basis. Research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a dividend of $2.10 per share. The ex-dividend date of this dividend was Monday, March 10th. This represents a $8.40 annualized dividend and a dividend yield of 1.60%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 54.19%.

Insider Buying and Selling

In other news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction dated Friday, January 17th. The shares were acquired at an average price of $511.57 per share, with a total value of $511,570.00. Following the completion of the purchase, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. The trade was a 28.57 % increase in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. 0.33% of the stock is currently owned by corporate insiders.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.